SPONSOR
Wake Forest University Health Sciences
Total Trials
22
Recruiting
22
Phases
Phase 2, Phase 3, Phase 4
Conditions studied: Opioid-use DisorderCocaine Use DisorderOpioid UseCocaine UseSubstance UseMethamphetamine AbuseMethamphetamine-dependenceMusculoskeletal InjuryAcute Ischemic StrokeHead and Neck Squamous Cell Carcinoma
Wake Forest University Health Sciences is a clinical research sponsor with 22 registered studies on ClinicalTrials.gov, of which 22 are actively recruiting participants. Research covers conditions including Opioid-use Disorder, Cocaine Use Disorder, Opioid Use, Cocaine Use.
The trial portfolio spans Phase 2, Phase 3, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Wake Forest University Health Sciences
How many clinical trials has Wake Forest University Health Sciences sponsored?
ClinicalMetric currently tracks 22 clinical trials sponsored by Wake Forest University Health Sciences, of which 22 are actively recruiting participants. These trials cover conditions including Opioid-use Disorder, Cocaine Use Disorder, Opioid Use. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Wake Forest University Health Sciences research focus on?
Wake Forest University Health Sciences clinical trials span Opioid-use Disorder, Cocaine Use Disorder, Opioid Use, Cocaine Use, Substance Use, and additional conditions. The research pipeline includes Phase 2, Phase 3, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Wake Forest University Health Sciences clinical trial?
To participate in a Wake Forest University Health Sciences trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Wake Forest University Health Sciences trials with current recruitment status updated daily.
Clinical Trials by Wake Forest University Health Sciences
NCT04927143
Recruiting
Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives
Opioid-use Disorder
NCT05780502
Recruiting
Use of an Integrated Orthotic and Rehabilitation Initiative for Treatment of Lower Extremity Musculoskeletal Disorders
Musculoskeletal Injury
NCT07638462
Recruiting
RIsE Stroke Mobility Study
Acute Ischemic Stroke
NCT04375384 Phase 2
Recruiting
Cetuximab After Immunotherapy for the Treatment of Head and Neck Squamous Cell Cancer
Head and Neck Squamous Cell Carcinoma
NCT07092566 Phase 3
Recruiting
R.E.C.K vs Exparel in Robotic Nephrectomy
Renal Carcinoma
NCT07107737
Recruiting
Physician Engagement in EMS Transport Refusal Rates
Refusal of Transport
NCT07119489
Recruiting
A Novel Dialectical Behavior Therapy Brief Group Intervention for Cigarette Smoking by Patients With Cancer: An Open Clinical Trial
Smoking Behavior
NCT06697808
Recruiting
Cranial Ultrasound for Point of Care Intracranial Pathology Detection in Pediatrics
Traumatic Brain Injury
NCT05721781
Recruiting
Reducing Risk for Infective Endocarditis
Bacteremia
NCT07693699
Recruiting
Optimizing Sustainable Cuff Access and Training Pathways for Self-Measured Blood Pressure Monitoring in Primary Care
Hypertension
NCT05525663
Recruiting
Physical Rehabilitation for Older Patients With Acute Heart Failure With Preserved Ejection Fraction
Heart Failure With Preserved Ejection Fraction
NCT06866964 Phase 2
Recruiting
A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboembolism in Patients With Advanced Germ Cell Tumors Receiving Chemotherapy
Germ Cell Tumor
NCT05206500 Phase 4
Recruiting
NextGen - Clinical Implication of Next Generation Sequencing
Urinary Tract Infections
NCT06669416
Recruiting
Taste Alterations Study
Chemotherapy Side Effects
NCT05828823
Recruiting
Incremental Hemodialysis: The TwoPlus Trial
End-Stage Kidney Disease
NCT06945042
Recruiting
ONC-LEUK-2406: The Impact of Systematic Financial Navigation in Acute Myeloid Leukemia
Acute Myeloid Leukemia
NCT07291297 Phase 2
Recruiting
Metformin Hydrochloride in Combination With Standard of Care Systemic Therapy in Previously Untreated Advanced Unresectable or Metastatic Soft Tissue Sarcoma
Sarcoma Metastatic
NCT07237191
Recruiting
Geriatric Distal Femur
Articular Fractures
NCT03777267
Recruiting
Cereset Research Exploratory Study
Neurological Diseases or Conditions
NCT03998202
Recruiting
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
Colorectal Cancer
NCT07525219 Phase 3
Recruiting
Suzetrigine Frame Trial Comparing Suzetrigine and Acetaminophen
Analgesic Efficacy
NCT02422641 Phase 2
Recruiting
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
Metastatic Breast Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology